CRISPR-Cas9 has transformed genetic engineering from a laborious process into a precise, affordable tool. But the 2018 He Jiankui scandal demonstrated the technology's potential for misuse, triggering global debates about germline editing, enhancement, and the governance of transformative biotechnology.